Therapeutic Effects of the Processing of Positive Memories Technique on Posttrauma Health
NCT ID: NCT06680193
Last Updated: 2024-11-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
70 participants
INTERVENTIONAL
2022-03-11
2024-06-05
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Examining Effects of a Therapeutic Focus on Positive Memories on Post-Trauma Health
NCT05523453
Characterization and Modulation of Traumatic Memories in PTSD Patients Using TMS
NCT06372639
Neurobehavioral Moderators of Post-traumatic Disease Trajectories
NCT03756545
PTSD Among Victims of Sexual Abuse and Changes in Structural and Functional Brain Connectivity
NCT01405495
Short-Term Recall and Reprocess Therapy for Post Traumatic Stress Disorder (PTSD)
NCT06826937
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Considering this literature, the Processing of Positive Memories Technique (PPMT) was developed as a promising new treatment approach for posttraumatic stress disorder (PTSD), which involves detailed narration and processing of specific positive autobiographical memories. This study uses an innovative research protocol that combines case-series design and daily diary approaches to the effects of PPMT on daily affect, daily cognitions, and daily PTSD symptoms. It is hypothesized that at the daily level, in comparison to their an individual's pre-PPMT levels, following the PPMT intervention, participants will report (1) a lower count of endorsed daily PTSD symptoms, (2) increases in daily positive affect and decreases in daily negative affect, (3) increases in positive affect reactivity to daily positive events, and (4) decreases in daily posttrauma cognitions.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Processing of Positive Memories Technique
PPMT was administered as a 4-session protocol in this arm.
Processing of Positive Memories Technique
PPMT was administered weekly as a 4-session protocol. In session 1, participants receive psychoeducation on PTSD symptoms, an overview of PPMT, and are assessed for psychological symptoms. Sessions 1-4 involve the detailed processing of a salient positive autobiographical memory to elicit "values, affect, strengths, and thoughts" related to that positive memory. Homework assignments include listening to an audio recording of that memory, completing a "values, affect, strengths, and thoughts" log, and engaging in a behavioral activity. In session 4, the therapist also reviews psychological symptoms and addresses termination.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Processing of Positive Memories Technique
PPMT was administered weekly as a 4-session protocol. In session 1, participants receive psychoeducation on PTSD symptoms, an overview of PPMT, and are assessed for psychological symptoms. Sessions 1-4 involve the detailed processing of a salient positive autobiographical memory to elicit "values, affect, strengths, and thoughts" related to that positive memory. Homework assignments include listening to an audio recording of that memory, completing a "values, affect, strengths, and thoughts" log, and engaging in a behavioral activity. In session 4, the therapist also reviews psychological symptoms and addresses termination.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* endorsing a trauma with posttrauma symptoms
* access to an electronic device with internet capabilities
* working knowledge of English
* being a current resident of the Dallas Fort Worth metroplex
* willingness and availability to participate in approximately 10 weeks of this study (including 4 therapy sessions)
* willingness to be video-recorded during sessions for quality control purposes
Exclusion Criteria
* currently in therapy with a mental health provider
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Haifa, Israel
UNKNOWN
University of North Texas, Denton, TX
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of North Texas
Denton, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Greene T, Contractor AA, Dicker-Oren SD, Fentem A, Sznitman SR. The Effects of the Processing of Positive Memories Technique on Posttrauma Affect and Cognitions Among Survivors of Trauma: Protocol for a Daily Diary Study. JMIR Res Protoc. 2024 Jan 12;13:e51838. doi: 10.2196/51838.
Rodenbaugh MM, Thompson LM, Sznitman SR, Jin L, Contractor AA. Refining processing of positive memories technique: client perspectives on components, format, and feasibility. Eur J Psychotraumatol. 2025 Dec;16(1):2563197. doi: 10.1080/20008066.2025.2563197. Epub 2025 Oct 9.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2020017
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
IRB-21-420
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.